BillionToOne
The Research Associate Intern at BillionToOne contributes to the development of high-impact molecular diagnostic products for oncology and prenatal medicine, working alongside senior scientists to move assays from research prototypes to clinical applications. This on-site role in Menlo Park, CA, offers early-career students the opportunity to utilize cutting-edge molecular techniques and next-generation sequencing to directly impact patient outcomes. The position provides a strong foundation for a scientific career through mentorship in interdisciplinary fields like genomics and bioinformatics.
Headquarters
Menlo Park, California, United States
Company Size
201-500 employees
Founded
2016
BillionToOne is a molecular diagnostics company that develops blood-based tests for prenatal screening and oncology, with a focus on detecting rare genetic variants in cell-free DNA. Its proprietary Quantitative Counting Template technology powers noninvasive prenatal screening and liquid biopsy assays used by healthcare providers and clinical laboratories. The company operates in the genomics and precision diagnostics industry.
BillionToOne Market Share Gains Raise Questions On Undervalued BLLN Stock
4 days ago
BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut
Nov 6, 2025
BillionToOne’s Single-Molecule Next-Generation Sequencing Platform Redefines Molecular Diagnostics for Prenatal and Oncology Care 404148
9 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BillionToOne.
19% below the average for this role
BillionToOne Shares Surge Following Firm's $273M IPO
Nov 6, 2025
Research Technician I
Ontario Institute for Cancer Research
Research Assistant - Molecular Haematology
Peter MacCallum Cancer Centre
Molecular Research Technician I
Centers for Disease Control and Prevention
Molecular Research Technician I
Centers for Disease Control and Prevention
Molecular Research Technician I
Centers for Disease Control and Prevention
Molecular Research Technician I
Centers for Disease Control and Prevention